PPARγ antagonist Gleevec improves insulin sensitivity and promotes the browning of white adipose tissue.
Choi S, Kim ES, Jung JE, Marciano DP, Jo A, Koo JY, Choi SY, Yang YR, Jang HJ, Kim EK, Park J, Kwon HM, Lee IH, Park SB, Myung KJ, Suh PG, Griffin PR, Choi JH
Diabetes., 2016
32
Novel phosphorylation of PPARγ ameliorates obesity-induced adipose tissue inflammation and improves insulin sensitivity.
Choi S, Jung J, Yang YR, Kim E, Jang H, Kim E, Kim IS, Lee J, Kim J, Seo JK, Kim J, Park J, Suh PG, Choi JH
Cellular Signaling, 2015
33
Hyperglycemia as a risk factor for cancer progression.
Ryu TY, Park J*, and Scherer P.E*
Diabetes & Metabolism Journal, 2014
34
Revisiting PPARg as a target for the treatment of metabolic disorders.
Choi S, Park J, and Choi J.H
BMB Reports., 2014
35
Obesity and Cancer: mechanisms underlying tumour progression and recurrence.
Park J, Morely S.T, Kim M, Clegg D, and Scherer P.E
Nature Reviews Endocrinology, 2014.08
36
ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue.
Kim M, Neinast M, Frank A, Sun K, Park J, Zehr J, Vishvanath L, Morselli E, Amelotte M, Palmer B, Gupta R, Scherer P.E, and Clegg D.
Molecular Metabolism, 2014.06
37
MitoNEET-Mediated Effects on Browning of White Adipose Tissue.
Kusminski C.M, Park J, and Scherer P.E.
Nature Communications., 2014.05
38
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction.
Sun K#, Park J#, Gupta O, Holland W.L, Auerbach P.L, Zhang N, Marangoni R.G, Nicoloro S.M, Czech M.P, Varga J, Ploug T, An Z, and Scherer P.E.
Nature Communications., 2014.03
39
Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity.
Lackey DE, Burk DH, Ali MR, Mostaedi R, Smith WH, Park J, Scherer PE, Seay SA, McCoin CS, Bonaldo P, Adams SH
Am J Physiol Endocrinol Metab, 2014.02
40
Inhibition of Endotrophin, a Cleavage Product of Collagen VI, Confers Cisplatin Sensitivity to Tumors.